Taylor Wessing advises on Europe's largest venture capital fund raising this year

CLIENT

MPM Capital

VALUE

$59.8m

TRANSACTION

Fundraising

DESCRIPTION

Taylor Wessing has acted for MPM Capital, a global investment firm focused solely on investing in life sciences, in its role as lead investor in a $59.8m private venture capital financing for Oxagen Limited, a drug discovery and development company.